Surgical Treatment of Peri-implantitis

• Status: Completed
• Trial end date: 2014-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this randomized controlled clinical trial is to evaluate the outcome of treatment of peri-implantitis with or without systemic antibiotics.

Specific aims are to analyze (i) the effect of systemic antibiotics and local antiseptics on the healing process, and (ii) the risk for recurrence of disease following surgical treatment of peri-implantitis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Göteborg University
• Collaborator: The Swedish Research Council
• Treatments: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotics, Antitubercular; Chlorhexidine; Chlorhexidine gluconate

Criteria

Inclusion Criteria:

• peri-implant probing pocket depth > 7 mm on at least one aspect of the implant, together with BOP and/or suppuration,

• marginal bone loss > 3mm as detected in radiographs.

Exclusion Criteria:

• implant mobility,

• peri-implantitis associated bone defects not suitable for pocket elimination therapy,

• systemic diseases that could influence the outcome of the therapy,

• penicillin allergy.